Selective thrombosis of tumor blood vessels in mammary adenocarcinoma implants in rats

American Journal of Pathology

Volumn 159, Issue 1, 2001, Pages 245-251

  Samoszuk, Michael K ^a,b   Su, Min Ying ^a   Najafi, Ahmad ^a   Nalcioglu, Orhan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM PENTETATE; HEPARIN ANTAGONIST; PROTAMINE;

ADENOCARCINOMA; ANIMAL; ARTICLE; CANCER TRANSPLANTATION; CHEMICALLY INDUCED DISORDER; EXPERIMENTAL NEOPLASM; FEMALE; FISCHER 344 RAT; INTRAVENOUS DRUG ADMINISTRATION; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT; THROMBOSIS; VASCULARIZATION;

ADENOCARCINOMA; ANIMALS; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HEPARIN ANTAGONISTS; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MAMMARY NEOPLASMS, ANIMAL; NEOPLASM TRANSPLANTATION; PROTAMINES; RATS; RATS, INBRED F344; THROMBOSIS;

EID: 0035406062     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)61690-2     Document Type: Article

References (39)

1. Aaltomaa S, Lipponen P, Kosma VM: Mast cells in breast cancer. Anticancer Res 1993, 13:785-788
2. Kankukunen JP, Harvima IT, Naukkarinen A: Quantitative analysis of tryptase and chymase containing mast cells in benign and malignant breast lesions. Int J Cancer 1997, 72:385-388
3. Thorensen S, Tangen M, Hartveit F: Mast cells in the axillary nodes of breast cancer patients. Diagn Histopathol 1982, 5:65-67
4. Roche WR: The nature and significance of tumour-associated mast cells. J Pathol 1986, 148:175-182
5. Dabbous MK, Haney L, Nicolson GL, Eckley D, Woolley DE: Mast cell modulation of tumour cell proliferation in rat mammary adenocarcinoma 13762NF. Br J Cancer 1991, 63:873-878
6. Smith TJ, Hougland MW, Johnson DA: Human lung tryptase. Purifcation and characterization. J Biol Chem 1984, 259:11046-11051
7. Schwartz LB, Bradford TR: Regulation of tryptase from human lung mast cells by heparin. Stabilization of the active tetramer. J Biol Chem 1986, 261:7372-7379
8. Alter SC, Metcalf DD, Bradford TR, Schwartz LB: Regulation of human mast cell tryptase. Effects of enzyme concentration, ionic strength and the structure and negative charge density of polysaccharides. Biochem J 1987, 248:821-827
9. Stack MS, Johnson DA: Human mast cell tryptase activates single-chain urinary-type plasminogen activator (pro-urokinase). J Biol Chem 1994, 269:9416-9419
10. Eli Lilly: Protamine sulfate. Physician's Desk Reference, Montvale, NJ, Medical Economics, 2001, p 1768
11. Su MY, Najafi AA, Nalcioglu O: Regional comparison of tumor vascularity and permeability parameters measured by albumin-Gd-DTPA and Gd-DTPA. Magn Reson Med 1995, 34:402-411
12. Su MY, Muhler A, Lao X, Nalcioglu O: Tumor characterization with dynamic contrast-enhanced MRI using MR contrast agents of various molecular weights. Mag Reson Med 1998, 39:259-269
13. Su MY, Wang Z, Roth GM, Lao X, Samoszuk MK, Nalcioglu O: Pharmacokinetic changes induced by vasomodulators in kidneys, livers, muscles, and implanted tumors in rats as measured by dynamic Gd-DTPA-enhanced MRI. Magn Reson Med 1996, 36:868-877
14. Rosenberg RD, Aired WC: Vascular-bed-specific hemostasis and hypercoagulable states. N Engl J Med 1999, 340:1555-1564
15. Costantini V, Zacharski LR, Memoli VA, Kudryk BJ, Disiel W, Rousseau SM: Fibrinogen deposition without thrombin generation in primary human breast cancer tissue. Cancer Res 1991, 51:349-353
16. Shoji M, Hancock WW, Abe K, Micko C, Casper KA, Baine RM, Wilcox JN, Danave I, Dillehay D, Matthews E, Contrino J, Morrissey JH, Gordon S, Edgington TS, Kudryk B, Kreutzer DL, Rickles FR Activation of coagulation and angiogenesis in cancer. Am J Pathol 1998, 152:399-411
17. Contrino J, Hair G, Dreutzer DL, Rickles FR In situ detection of tissue factor in vascular endothelial cells: corelation with the malignant phenotype of human breast disease. Nat Med 1996, 2:209-215
18. Nagy JA, Meyers MS, Masse EM Herzberg KT, Dvorak HF: Pathogenesis of ascites tumor growth: fibrinogen influx and fibrin accumulation in tissues lining the peritoneal cavity. Cancer Res 1995, 55: 369-375
19. Nagy JA, Morgan ES, Herzberg KT, Manseau EJ, Dvorak AM, Dvorak HF: Pathogenesis of ascites tumor growth: angiogenesis, vascular remodeling, and stromal formation in the peritoneal lining. Cancer Res 1995, 55:376-385
20. Hejna M, Raderer M, Zielinski CC: Inhibition of metastases by anticoagulants. J Natl Cancer Inst 1999, 91:22-36
21. Roche WR: The nature and significance of tumour-associated mast cells. J Pathol 1986, 148:175-182
22. Starkey JR, Crowle PK, Taubenberger S: Mast-cell-deficient W/Wv mice exhibit a decreased rate of tumor angiogenesis. Int J Cancer 1988, 42:48-52
23. Dethlefsen SM, Matsuura N, Zetter BR: Mast cell accumulation at sites of murine tumor implantation: implications for angiogenesis and tumor metastasis. Invasion Metastasis 1994-1995, 14:395-408
24. Tomita M, Matsuzaki Y, Onitsuka T: Effect of mast cells on tumor angiogenesis in lung cancer. Ann Thorac Surg 2000, 69:1686-1690
25. Nielsen HJ, Hansen U, Christensen IJ, Reimert CM, Brunner N, Moes F: Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue. J Pathol 1999, 189:487-495
26. Arrieta O, Guevara P, Reyes S, Ortiz A, Rembao D, Sotelo J: Protamine inhibits angiogenesis and growth of C6 rat glioma; synergistic effect when combined with carmustine. Eur J Cancer 1998, 34:2101-2106
27. Trabucchi E, Radaelli E, Marazzi M, Foschi D, Musazzi M, Veronesi AM, Montorsi W: The role of mast cells in wound healing Int J Tissue React 1988, 10:367-372
28. O'Brien T, Cranston D, Fuggle S, Bicknell R, Harris AL: The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with poor outcome in patients with invasive cancers. Cancer Res 1996, 56:2515-2518
29. Iniu Y, Higashiyama S, Kawata S, Tamura S, Miyagawa J, Taniguchi N, Matsuzawa Y Expression of heparin-binding epidermal growth factor in human hepatocellular carcinoma. Gastroenterology 1994, 107:1799-1804
30. Kobrin MS, Funatomi H, Friess H, Buchler MW, Stathis P, Korc M: Induction and expression of heparin-binding EGF-like growth factor in human pancreatic cancer. Biochem Biophys Res Comm 1994, 202: 1705-1709
31. Shain SA, Ke LD, Wond G, Karaganis AG: Rat prostate cancer cell line-specific production and apparent secretion of heparin-binding growth factors. Cell Growth Differ 1992, 3:249-258
32. Lupu R, Wellstein A, Sheridan J Ennis BW, Zyugmaier G, Katz D, Lippman ME, Dickson RB: Purification and characterization of a novel growth factor from human breast cancer cells. Biochemistry 1992, 31:7330-7340
33. Toil M, Inada K, Suzuki H, Tommaga T: Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Breast Cancer Res Treat 1995, 36:193-204
34. Brown LF, Berse B Jackman RW, Tognazzi K, Guidi AJ, Dvorak HF, Senger DR, Connoly JL, Schnitt SJ: Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol 1995, 26 86-91
35. Smith J, Yelland A, Baillie R, Coombes RC Acidic and basic fibroblast growth factors in human breast tissue. Eur J Cancer 1994, 30:496-503
36. Fang W, Hartmann N, Chow DT, Riegel AT, Wellstein A: Pleiotrophin stimulates fibroblasts and endothelial and epithelial cells and is expressed in human cancer. J Biol Chem 1992, 267:25889-25897
37. Wellstein A, Fang WJ, Khatri A, Lu Y, Swain SS, Sasse J, Riege AT, Lippman ME: A heparin-binding growth factor secreted from breast cancer cells homologous to a developmentally regulated cytokine. J Biol Chem 1992, 267:2582-2587
38. Gitay-Goren H, Soker S, Vlodavsky I, Neufeld G: The binding of vascular endothelial growth factor to its receptors on cell surface-associated heparin-like molecules. J Biol Chem 1992, 267:6093-6098
39. Roche WR: Mast cells and tumour angiogenesis the tumor-mediated release of an endothelial growth factor from mast cells. Int J Cancer 1985, 36:721-728